Search results for: 'data intelligent pharma'

25 Feb 2020  |  North America  |  Market Research

Artificial Intelligence in Enterprise Communications and Collaboration, Global, 2019

Assisted and Augmented Intelligence is Making Greater Headway in Workplaces

Infographics

×

Key Issues Addressed

This research study focuses on how AI is making inroads into the enterprise communications and collaboration arena. Subsequent to the dynamic technology shifts from on-premises enterprise communications to cloud-based communications services, the industry is further warming up to embrace AI and integrate it with multifarious communication channels...

This research service on the global pharma extractables and leachables (E&L) testing market addresses the market sizing, emerging trends, and technologies, and provides a snapshot of the key participants in the market. The base year for the deliverable is 2015 while forecasts have been provided from 2016 to 2020. The pharma E&L testing market is ...

21 Dec 2023  |  North America  |  Market Research

Global Healthcare Data Interoperability Growth Opportunities Forecast to 2028

Systems to Move Beyond Integration Toward Semantic Interoperability

Infographics

×

Interoperability refers to the ability to exchange data among different systems or applications and make use of the incoming data. In healthcare, this generally means the ability to share data between electronic health record (EHR) systems and other health IT applications, such as a clinical decision support system (CDSS), computerized physician or...

In some ways, digitization doesn’t change what we do, only how we do it. Consider the safeguarding of precious intellectual assets (such as documents and creative works). Whether physical or digital, such assets may need to be protected from: --Access by unauthorized persons – Private documents need to remain private. Physical assets may be stored...

This project provides an overview of the effects of generative AI (Gen AI) on the healthcare and life science industry and numerous growth opportunities, including how it could overcome regulatory and cybersecurity obstacles, address the build-borrow-buy conundrum, and impact the value chain of pharmaceutical companies, medical device developers, p...

16 Apr 2015  |  North America  |  Market Research

Big Data Opportunities in the US Medical Imaging Market

Assessing Market Opportunities for Big Data Management and Big Data Analytics in Medical Imaging

Infographics

×

Medical imaging data volumes will soon be approaching the petabyte range forcing providers to explore Big Data tools to help capture, manage, view, and analyze data. Leading medical imaging and non-healthcare IT vendors are investing in solutions as well as business strategies to support the healthcare industry as it progresses on the Big Data jour...

The COVID-19 pandemic impact on the biopharmaceutical industry has increased patient-centricity and the adoption of eClinical services digital platforms to manage clinical development programs. Capital investments and co-development recorded an uptick over the last 2 years, focusing on advancing clinical assets and expanding the number of Phase 2 a...

Despite the term patient centricity gaining currency in the industry, there is a degree of variability in a companies’ approach and strategic priorities. Frost & Sullivan sees digitization playing a critical role in transforming the clinical trial model from traditional, high-cost, and difficult-to-access centralized settings to more patient-centri...

12 Aug 2020  |  North America  |  Market Research

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

Infographics

×

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...